Abstract

NRF2/KEAP1 and Wnt/β-catenin in the multistep process of liver carcinogenesis in humans and rats.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinical and Pathological Characteristics of KEAP1- and NFE2L2-Mutated Non-Small Cell Lung Carcinoma (NSCLC).
Sebastian Michels ... Monika Serke
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 24
Sebastian Michels, et. al.Sebastian Michels ... Monika Serke
01 Jul 2018
Role of KEAP1/NFE2L2 Mutations in the Chemotherapeutic Response of Patients with Non-Small Cell Lung Cancer.
Millie Das ... Jessica A Hellyer
Clinical cancer research : an official journal of the American Association for Cancer Research | VOL. 26
Millie Das, et. al.Millie Das ... Jessica A Hellyer
01 Jan 2020
2034P - Genetic landscape of KEAP1 and NFE2L2 mutated cancers from the AACR GENIE database
M Zaki ... V Pahalyants
Annals of Oncology | VOL. 30
M Zaki, et. al.M Zaki ... V Pahalyants
01 Oct 2019
NFE2L2 synergizes with beta‐catenin gene mutations to induce HCC in patients and mice
Sucha Singh ... Junyan Tao
The FASEB Journal | VOL. 33
Sucha Singh, et. al.Sucha Singh ... Junyan Tao
01 Apr 2019
View more papers

More From: Hepatology (Baltimore, Md.)

Paper Title
Journal
Date
Author
Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study.
Stanislas Pol ... Joseph S Doyle
Hepatology (Baltimore, Md.) | VOL. -
Stanislas Pol, et. al.Stanislas Pol ... Joseph S Doyle
20 May 2024
Deep learning and digital pathology powers prediction of HCC development in steatotic liver disease.
Takuma Nakatsuka ... Kazuhiko Koike
Hepatology (Baltimore, Md.) | VOL. -
Takuma Nakatsuka, et. al.Takuma Nakatsuka ... Kazuhiko Koike
20 May 2024
The obstacle is the way: Finding a path to hepatitis C elimination.
Vincent Lo Re ... Andrew Arohnson
Hepatology (Baltimore, Md.) | VOL. -
Vincent Lo Re, et. al.Vincent Lo Re ... Andrew Arohnson
16 May 2024
Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure.
Rita Feio-Azevedo ... Schalk Van Der Merwe
Hepatology (Baltimore, Md.) | VOL. -
Rita Feio-Azevedo, et. al.Rita Feio-Azevedo ... Schalk Van Der Merwe
16 May 2024
View more papers